Current Location：Home - About - Enterprise yearbook
The cross-border commissioned production to Zhongshan United Laboratories of Vitamin C Effervescent Tablets by Hong Kong United Laboratories was officially launched for production and sold in Mainland China, which was the first cross-border production of pharmaceutical products in the Guangdong-Hong Kong-Macao Greater Bay Area.
The United Laboratories’ Piperacillin Sodium and Tazobactam Sodium for Injection (specification: 2.25g) passed the quality and efficacy consistency evaluation of generic drugs.
The United Laboratories was honored with the “County-level Health Development Contribution Award”.
The United Laboratories was ranked 16th in the “Top 100 Chemical and Pharmaceutical Enterprises in China for 2022”.
The United Laboratories’ Semaglutide Injection for weight management indication was approved for clinical trials.
The United Laboratories’ Insulin Degludec and Liraglutide Injection was approved for clinical trials.
Zhuhai United Laboratories was honored with the title of “the Pioneer of the Pharmaceuticals Industry in Fighting Covid-19 in Guangdong Province”.
The United Laboratories’ Piperacillin Sodium and Tazobactam Sodium for Injection (specification: 4.5g) was listed among the eighth batch of National Centralised Procurement of Pharmaceuticals.
The United Laboratories’ Amoxicillin Capsules (specification: 0.5g) passed the quality and efficacy consistency evaluation of generic drugs.
TUL12101 Eye Drops, a class I new drug for dry eye syndrome, was approved for clinical trials.
The biopharmaceutical sector of The United Laboratories was settled in Hengqin, Zhuhai, and Chairman Mr. Tsoi Hoi Shan, on behalf of the Group, signed a cooperation agreement with the Guangdong-Macao In-Depth Cooperation Zone in Hengqin.
Zhuhai United Laboratories was ranked 63rd in the “Top 500 Manufacturing Enterprises in Guangdong Province for 2022”.
Zhuhai United Laboratorieswas ranked 22th of the "2021 Top 100 Pharmaceutical Enterprises in China".
The Sodium Hyaluronate Eye Drops (0.3% (0.4 ml: 1.2 mg)) of Zhongshan United Laboratorieswere approved for sale, andthe quality and efficacy of the eye drops were deemed to be consistent with those of the brand-name version.
The Amoxicillin of theUnited Laboratorieswon the Antibiotic Brand Gold Award of the "Health Industry Brand List for 2022" of CPEO.
The United Laboratories was selected as one of CPEO’s"Top 100 Enterprises with Comprehensive Competitiveness in the Pharmaceutical Industry for 2022".
The Sodium Hyaluronate Eye Drops (0.1% (0.4 ml: 0.4 mg)) of Zhongshan United Laboratorieswere approved for sale, andthe quality and efficacy of the eye drops were deemed to be consistent with those of the brand-name version.
The registration application for clinical trials of TUL12101 Eye Drops, a new medicine of Class I of Zhuhai United Laboratories for dry eyes was received by the competent authority.
TUL01101 Cream (0.5%, 1% and 2%), a new medicine of Class Iof Zhuhai United Laboratoriesfor atopic dermatitiswas approved for clinical trials.
The Semaglutide Injection of the United Bio-Technology (Hengqin) Co., Ltd. was approved for clinical trials.
The United Laboratories was awarded the "Most Valuable Listed Company" for 2022 by Sina Finance in HK and US stock markets.
The sterile active substances and other products of the United Animal Healthcare (Inner Mongolia) were up to the standard of the new GMP for veterinary medicines.
The Amoxicillin Sodium (a sterile active substance of antibiotics) and other products of Zhuhai United Laboratories were awarded a certificate of GMP compliance by Spanish Agency of Medicines and Medical Products (AEMPS).
The registration application for clinical trials of Semaglutide Injection of the United Bio-Technology (Hengqin) Co., Ltd. was received by the competent authority.
The "Biological Products and Chemical and Pharmaceutical Preparations Production Expansion and Efficiency Enhancement Technological Transformation Project" of Zhongshan United Laboratories was one of the special projects for the development of the industry in Zhongshan for 2022.
The United Laboratories was ranked 16th of the "Top 100 Chemical and Pharmaceutical Enterprises in China for 2021".
The United Animal Healthcare (Inner Mongolia) and Muyuan Foods Co., Ltd. signed an agreement to establish a joint venture to cooperate in the field of veterinary medicines.
The subsidized project related tothe consistency evaluation of Tenofovir Dipivoxil Fumarite Tablets, Memantine Hydrochloride Tablets and Glipizide Tablets of Zhongshan United Laboratorieswas one of the special projects for the development of the health and pharmaceutical industry in Zhongshan for 2021.
The "Technological Development and Industrialization Project of Insulin Glargine for Diabetes Treatment" jointly reported by Zhongshan United Laboratories and Zhuhai United Bio-Pharmaceutical Co., Ltd. won the first prize of 2021 Zhuhai Science and Technology Progress Award.
An evaluation showed that the quality and efficacy of the Tazobactam Sodium/Piperacillin Sodium for Injection (4.5 g) of Zhongshan United Laboratories were consistent with those of the brand-name version.
The Insulin Degludec and Insulin Aspart Injection of the United Bio-Technology (Hengqin) Co., Ltd. was approved for clinical trials.
Zhuhai United Laboratories was selected as one of the "Top 10 Pharmaceutical and Health Manufacturing Enterprises in Zhuhai for 2021".
An evaluation showed that the quality and efficacy of the Cefuroxime Axetil Tablets (0.125 g) of Zhongshan United Laboratories were consistent with those of the brand-name version.
An evaluation showed that the quality and efficacy of the Biapenem for Injection (0.3 g) of Zhuhai United Laboratories were consistent with those of the brand-name version.
The project "Innovation and Application of New Products for the Prevention and Control of Serious Diseases of Dogs and Cats" of the United Animal Healthcare (Inner Mongolia) won the second prize of Guangdong Provincial Science and Technology Progress Award for 2021.
The United Laboratories was listed on the "Top 25 Pharmaceutical Stocks" of the "Top 100 Hong Kong Stocks".
The United Laboratories won the “Best ESG Award” of the 5th China Excellence IR.
The United Bio-Technology (Hengqin) Co., Ltd. was awarded “Emerging Enterprise of Top 50 Innovative Biotechnology Enterprises in the Fourth Guangdong-Hong Kong-Macao Greater Bay Area”.
According to the latest ESG rating report from MSCI (Morgan Stanley Capital International), The United Laboratories (03933.HK) has been rated as grade A and its ESG rating has been improved for the past two consecutive years.
Quality Inspection Center of Zhuhai United Laboratories has been accredited as a national laboratory by China National Accreditation Service for Conformity Assessment (CNAS) for 11 consecutive years.
The United Laboratories won all the bid of six groups of insulin products in the Sixth Batch of National Centralized Procurement of Pharmaceuticals (specializing in insulin).
Twelve production lines of The United Animal Healthcare passed the acceptance by the Veterinary Bureau of Inner Mongolia Agriculture and Animal Husbandry Department according to the new edition of GMP qualified production lines for veterinary drugs.
Zhuhai United Laboratories was awarded the “Outstanding Enterprise Brand of Exported Bulk Medicine” by China Pharmaceutical Industry Association.
Zhuhai United Laboratories was selected to be one of the “Top 100 Enterprises of Synthetical Competitiveness Index of Pharmaceutical Industry in 2020-2021” by CHEO (China Health Ecology Organization).
Zhuhai United Laboratories was awarded “2020 China Pharmaceutical Industry Top 100 Companies” (ranking the 20th) by China National Pharmaceutical Industry Information Center.
The United Laboratories (Inner Mongolia) Limited entered into a cooperation framework agreement on veterinary drugs with Zhejiang Apeloa Biotechnology Co., Ltd.
The United Laboratories won the honor of “China Top 100 Chemical Pharmaceutical Enterprises” by ranking the 16th.
The United Laboratories’ insulin aspart injection, insulin aspart 30 injection and insulin aspart API have been approved for commercialization.
Zhuhai United Laboratories was awarded the title of “Top 10 Enterprise in Pharmaceutical and Healthcare Manufacturing Industry in Zhuhai for 2020” by Zhuhai Industry and Information Technology Bureau.
The United Laboratories’ Semaglutide Injection received a notification of acceptance of clinical registration application.
The United Laboratories’ Memantine Hydrochloride Tablets (specification: 10mg) passed the quality and efficacy consistency evaluation of generic drugs.
Zhuhai United Laboratories was awarded “Enterprise Management Award” – Outstanding Enterprise for Green Development in the pharmaceutical industry during the “13th Five-Year Plan”.
The Amoxicillin Capsule (specification: 0.25g) submitted by The United Laboratories, Limited (Hong Kong) passed the quality and efficacy consistency evaluation of generic drugs.
The project of “Research on the technology of New Mucus-penetrating Nanocrystal Eye Drops” declared by The United Laboratories was granted The Zhuhai Industry – University – Research Cooperation and Basic and Applied Basic Research Projects subsidies.
Zhuhai United Laboratories was qualified as “High-tech Enterprise of Guangdong Province for 2020”.
Zhuhai United Laboratories Trading Company Limited was awarded as “Enterprise with Outstanding Contribution” and “Advanced Enterprise with Anti-epidemic Courage and Responsibility” in Zhuhai pharmaceutical industry for 2020 by the Zhuhai Pharmaceutical Circulation Industry Association.
Zhongshan United Laboratories was admitted as “Hong Kong and Macao Youth Talent Internship Practice Base”.
The United Laboratories won the first prize of Zhuhai Science and Technology Progress Award for 2020 for the project of Memantine Hydrochloride.
The United Laboratories (Inner Mongolia) successfully passed the authentication of Quality, Environmental, Occupational Health & Safety Management System.
The United Laboratories’ Tenofovir Dipivoxil Fumarate Tablets (specification: 300mg)obtained the drug registration certificate and deemed to have passed the quality and efficacy consistency evaluation of generic drugs.
The United Laboratories’ Glipizide Tablets (specification: 5mg) passed the quality and efficacy consistency evaluation of generic drugs.
Zhuhai United Laboratories was named “2019 Zhuhai 100 High-tech Enterprises of Comprehensive Innovation Strength” and “2019 Zhuhai 100 High-tech Enterprises of Economic Contribution”.
The United Laboratories was named “Most Socially Responsible Listed Company” at the 4th Golden Hong Kong Stocks Annual Awards.
The United Laboratories (Inner Mongolia) held the kick-off ceremony of “Reclaimed Water Reuse and Zero Emission Project”.
The United Laboratories launched “Map of National Diabetes Pharmacies” online.
The United Animal Healthcare (Inner Mongolia) Co., Ltd. was granted the Sanitation Permit for Enterprise Producing Disinfection Products.
The United Laboratories cumulatively donated over RMB4,000,000 and epidemic prevention materials of RMB1,000,000 worth to support the fight against COVID-19.
Category 1 new drug WXSH0150 for the treatment of moderate to severe active rheumatoid arthritis was approved for clinical trial.
The United Laboratories (Inner Mongolia) passed the GMP on-site inspection in respect of ampicillin, amoxicillin and clavulanate potassium mixed powder.
Zhuhai United Laboratories was named “Top 10 Companies of Comprehensive Competitiveness” and “Caring Company” at 2019 Zhuhai Pharmaceutical Industry Celebration of the 40th Anniversary of Reform and Opening Up by Zhuhai Pharmaceutical Circulation Association.
The United Laboratories won the honor of “2019 China 100 Chemical Pharmaceutical Enterprises” by ranking the 18th.
Zhuhai United Laboratories was awarded “2019 China Pharmaceutical Industry Top 100 Companies” (ranking the 21st) by China National Pharmaceutical Industry Information Center.
The United Laboratories was named “2020 Sina Finance Golden Kylin Most Valuable Hong Kong Stocks - Best IR Team”.
The United Laboratories was named “2019-2020 China Healthcare Enterprises of Best Investment Potential”.
Zhuhai United Laboratories was awarded six honors by China Pharmaceutical Industry Association, including “2020 China Pharmaceutical Industry Top 100 Companies with Comprehensive Strength” and “2020 Leading Export Brand of Bulk Medicine of China’s Pharmaceutical Industry”.
Mr. Tsoi Hoi Shan, Chairman of the Board, was named “Outstanding Innovative Entrepreneur” at the 3rd Zhongshan Non-Public Sector Phoenix Award.
The United Laboratories was named “10 Most Competitive Enterprises of National-level Foreign Trade Transformation and Upgrade Bases (Biopharmaceutics) of Zhuhai Jinwan District” and “2020 Special Contribution Award for Fighting COVID-19”.
The United Laboratories was named “Guangdong Private Enterprise of Outstanding Contribution in Fighting COVID-19”.
The United Laboratories was honored “2018 Golden Hong Kong Stocks – Most Valuable Pharmaceutical Company and Medical Stock”.
The United Laboratories was honored “Medical Technology Innovation Advanced Company of Zhuhai for 2018”.
The United Laboratories was further listed as one of the “China Top Ten Member Exporters of APIs”.
The United Animal Healthcare (Inner Mongolia) Co., Ltd. passed the “High-Tech Enterprise”certification.
“Double-Excellence Action – Grassroots Diabetes Prevention and Treatment Management Training Course” was kicked off in Zhengzhou, Henan Province.
“2019 Forum on Hospital Pharmacy Changes and Development in the Context of Healthcare and Medical Institution Reform”, sponsored by The Science and Technology Development Center of Chinese Pharmaceutical Association and co-sponsored by The United Laboratories,was held successfully in Zhuhai, Guangdong.
The United Laboratories Clinical Department (Guangzhou branch) was established.
The United Animal Healthcare (Inner Mongolia) Co., Ltd. was named “China’s Leading Domestic Brand” at Brand Summit China 2019.
The United Laboratories was awarded “Quality Suppliers and Partners in the World Market”and “Prize of Special Contribution for CCCMHPIE’s 30th Anniversary” by China Chamber of Commerce for Import & Export of Medicines & Health Products.
Mr. Tsoi Hoi Shan, Chairman of the Board of The United Laboratories, was honored as“Guangdong New Economy – Outstanding Entrepreneur” for the year of 2019.
The United Laboratories was listed among “2018 China Pharmaceutical Industry Top 100 Companies” and ranked 25th.
Powder injection of “Amoxicillin and Clavulanate Potassium for Injection”, a veterinary product developed by The United Animal Healthcare (Inner Mongolia) Co., Ltd., was approved for marketing.
The United Laboratories was awarded “2018 China Pharmaceutical Industry Top 100 Companies” (ranking the 22nd) by China National Pharmaceutical Industry Information Center.
The United Laboratories and Evergrande (Chengdu) entered into the Investment and Cooperation Agreement with respect to the equity interest of United Laboratories (Chengdu) and development of the Land.
Insulin degludee injection of The United Laboratories was approved for clinical trial.
Zhuhai United Laboratories was listed in the fourth batch of national green plant models issued by the Ministry of Industry and Information Technology.
Zhuhai United Laboratories was awarded “2019 China Pharmaceutical Industry Top 100 Companies with Comprehensive Strength” (ranking the 18th) and “Leading Export Brand of Bulk Medicine of China’s Pharmaceutical Industry” by China Pharmaceutical Industry Association.
The United Laboratories entered into a facility agreement for dual currency syndicated loans in the amount equivalent to up to HK$2 billion for a term of three years.
The Quality Control Center of Zhuhai United Laboratories passed the certification of China National Accreditation Service for Conformity Assessment (CNAS) for a second time.
“Study on Quality and Efficacy Consistency Evaluation of Amoxicillin Capsule (0.25g) and Cefuroxime Axetil Tablet (0.25g)” was named Zhongshan Healthcare Industry Development Project 2019 and granted financial subsidies.
“Technology Development of New Drug for Rheumatoid Arthritis Treatment” was named Zhongshan 4th Batch of Specially-Funded Technology Development Project 2019 and granted financial subsidies.
The United Laboratories (Inner Mongolia) passed the high-tech enterprise certification.
The insulin aspart project was granted with the Special Fund Subsidies for Supporting the Commercialization of Major Scientific and Technological Achievements of Guangdong Province.
Zhuhai United Laboratories passed the OHSAS18001 (Occupational Health and Safety Management System) Certification.
The United Laboratories was ranked the fourth largest western medicine exporter among the“China Foreign Trade List of Medicines” by China Chamber of Commerce for Import & Export of Medicines & Health Products.
The United Laboratories was granted the “China Foreign Trade List of Medicines – Top 50 APIs Exporters for 2017” & “China Top Ten Member Exporters of APIs” by China Chamber of Commerce for Import & Export of Medicines & Health Products.
Zhuhai United Laboratories was shortlisted for the “Key Enterprise of Industrial Development and Innovation-driven Enterprise of Jinwan District for 2018”.
The United Laboratories was awarded the “Medical Technology Innovation Advanced Company of Zhuhai for 2017” by Zhuhai Medical Association.
The amoxicillin capsule (specification: 0.25g) of The United Laboratories passed the consistency of quality and efficacy evaluation for generic drugs.
Zhuhai United Laboratories successfully passed the high-tech enterprise certification.
The Research and Development and Commercialization Project of the Diabetic Drug –Recombinant Human Insulin Series under the Genetic Engineering of The United Laboratories was awarded the “First Prize of the Science and Technology Progress Awards of Zhuhai”.
The United Laboratories was granted the “2018 Excellent Supplier and Cooperation Partner in International Market” by China Chamber of Commerce for Import & Export of Medicines & Health Products.
The United Laboratories (Inner Mongolia) successfully passed the GMP on-site inspection.
The United Laboratories (Inner Mongolia) donated drought relief funds of RMB300,000 to Bayannur City.
The cefuroxime axetil tablet (specification: 0.25g) of The United Laboratories passed the consistency of quality and efficacy evaluation for generic drugs.
Zhuhai United Laboratories was ranked at No. 24 of the “2017 Chinese Top 100 Pharmaceutical Enterprises” published by China National Pharmaceutical Industry Information Center.
The bulk medicine of clavulanate potassium, clavulanate potassium-microcrystalline cellulose (1:1) and clavulanate potassium-silica (1:1) of The United Laboratories (Inner Mongolia) obtained GMP certificate.
Mr. Choy Kam Lok, former Chairman of the Board of The United Laboratories, was titled as“Pharmaceutical Industry Outstanding Man in the 40 Years of Reform and Opening-up”
A total of 15 categories (30 products) of The United Laboratories were selected in the “National Essential Drugs List (2018 edition)”.
Zhuhai United Laboratories passed the EU GMP on-site inspection on sterile bulk medicine.
Zhuhai United Laboratories was honored as “Top 100 Industrial Enterprises in Terms of Comprehensive Strength in the Pharmaceutical Industry of China”, “Excellent Bulk Medicine Export Enterprise Brand in the Pharmaceutical Industry of China” and “Chinese Chemical Pharmaceutical Industry Anti-Infection Excellent Brand” by the Chinese Chemical Pharmaceutical Industry Association.
Liraglutide Injection of The United Laboratories was approved for clinical-trial.
“USLIN” (recombinant human insulin finished product series) of The United Laboratories was honored as the “Most Innovative Finished Product Series of China in 2018” by the China National Pharmaceutical Industry Information Center.
The United Laboratories (Inner Mongolia) was honored to be ranked among the “Third Batch of Green Manufacturer List” by the Ministry of Industry and Information Technology and was awarded the title of National Green Factory.
The United Laboratories was awarded as “Outstanding Pharmaceutical Enterprise for 40-Anniversary Reform and Opening-up in Guangdong”, amoxicillin capsules manufactured by The United Laboratories as “Pharmaceutical Innovative Products for 40-Anniversary Reform and Opening-up in Guangdong”.
“The United Laboratories Education Scholarship” was granted at Fujian Medical University and Central South University.
On August 3, 2017, The United Animal Healthcare (Inner Mongolia) Co., Ltd. passed the on-site acceptance inspection on veterinary drugs of GMP certification by experts from the Department of Agriculture and Husbandry of Inner Mongolia Autonomous Region.
In July 2017, Cai Haishan, Chairman of United Lab was honored the "Phoenix Award Top 10 Figures of Non-public Sectors of Economy of Zhongshan City".
On June 19, 2017, The United Laboratories International Holdings Limited was listed as one of the top 100 international medical enterprises of year 2017 and won the title of "Excellent Supplier and Cooperation Partner in International Market".
On June 12, 2017, Zhuhai United Lab won the "2015-2016 Voluntary Blood Donation Promotion Award of Zhuhai City".
In 2017, Zhuhai United Laboratories Co., Ltd. won the "Award of Active Environmental and Safety Promotion".
On June 2, 2017, the third United Lab educational scholarship was granted at Chongqing Medical University and the fourth United Lab Educational Scholarship Agreement was renewed. Cai Haishan, Chairman of United Lab was honored as a guest professor of the university.
In May 2017, United Lab carried out the public service activity themed "Care for Orphaned and Disabled Children", and donated domestic appliance and other living articles worth nearly RMB 30,000 to Zhuhai Municipal Social Welfare Center.
On May 13 and 14, 2017, an expert group from China National Accreditation Service (CNAS) carried out on-site review on the management and technology capacities of Zhuhai United Lab Quality Inspection Center, which was recognized by high comments from the CNAS for the third time.
On May 13, 2017, the trade delegation of Latin America and Caribbean Sea headed by Li Dapan, Director of the Ministry of Commerce visited Zhuhai United Lab for investigation and exchange.
On May 13, 2017, the insulin glargine USLEN was put on the market.
On April 29, 2017, the insulin API, penem preparations, memantine hydrochloride and penem antibiotic API were granted with the "Certificate of Catalog of Major Products for Promotion of Zhuhai Strategic Emerging Industry".
On April 26, 2017, United Lab entered a strategic cooperation framework agreement with Zhuhai Hengqing National Intellectual Property Platform.
On March 29, 2017, United Lab Zhongshan won five awards: 2016 Excellent Enterprise Award of Tanzhou Town, 2016 Economic Contribution Award of Tanzhou Town, 2016 Tax Contribution Award of Tanzhou Town, 2016 Fixed Asset Investment Award of Tanzhou Town and 2016 Technology Innovation Contribution Award of Tanzhou Town.
On March 26, 2017, United Lab was honored the "Excellent Unit of Enterprise Culture Building of Guangdong Province in Year 2016".
On March 6, 2017, the Chemical Test Group of the Test Center under Zhuhai United Laboratories Co., Ltd. won the title of "National Model Worker" granted by the All-China Federation of Trade Unions.
On March 16, 2017, United Lab was honored as one of the "Top 10 Member Enterprises of API Industry for Export in China".
In March 2017, United Lab's insulin glargine API and injection passed the GMP certification.
On February 23-24, 2017, United Lab participated in the "targeted poverty alleviation" activity organized jointly by the Federation of Industry and Commerce and Intellectual Sodality of Tanzhou Town, and went to Guangning County to exert our care to students there by supplying them with clothes and subsidies.
In February 2017, the memantine hydrochloride tablets and oral solution were incorporated into the coverage of national health insurance according to the new policy in 2017.
In February 2017, United Lab was listed one of the top 100 export enterprises of medical healthcare products of year 2016.
On January 19, 2017, the United Lab's drug for Alzheimer's disease, memantine hydrochloride "Yi Bei Qing" was renamed as memantine hydrochloride "Bang De Qing".
On January 13, 2017, United Lab Zhongshan donated drugs worth RMB 20,000 in the evening party of Zhongshan Tanzhou Charity Parade.
In January 2017, the memantine hydrochloride program won the first prize of scientific and technological progress of Zhongshan City for the year 2015.
The recombinant human insulin won the second prize of scientific and technological progress of Guangdong Province for the year 2016.
On January 13, 2017, United Lab was honored the "Most Valuable Pharmaceutical Enterprise of Year 2016".
On January 11, 2017, the United Laboratories (China) Co., Ltd. was evaluated as the "2016 Excellent Unit of Intellectual Property of Zhuhai City".
On January 6, 2017, Zhuhai United Laboratories Trading Co., Ltd. was selected as the "Deputy Chairman Unit" of Zhuhai Enterprises Association for Foreign Economic Cooperation, and general manager Zhen Shunteng was appointed as the "Standing Vice-chairman".
In early 2017, insulin glargine USLIN, an insulin human analogue developed by the United Lab using the DNA gene recombination technology was approved for marketing, and the cartridge specifications of insulin glargine injection pen obtained the approval (GYZZ S20160009) for production.
In December 2016, ten product series of United Lab passed the qualification accreditation of "2016 High and New Technology Products of Guangdong Province" and obtained the high and new technology product certificate. The product series comprise: Amoxy, Strong Amoxy, Ampicillin, Sai Fu Song, Sai Fu Bi, Strong Sai Fu Bi, Tazocin, Lian Jing Jing, A Di Xian, USLIN, consisting of 10 APIs and 20 preparations.
The memantine hydrochloride program won the first prize of scientific and technological progress of Zhongshan City for the year 2015.
In December 2016, United Lab received fund subsidy from 2016 Guangdong R&D Fund Project.
On December 20, 2016, the United Lab is evaluated as the "2016 Five-star Enterprise of Credit Risk Management".
On December 2, 2016, the award ceremony of "United Lab Medical Educational Scholarship" was held at Central South University.
On November 15, 2016, United Lab was honored as one of the "Top 100 Industrial Enterprises with the Strongest Comprehensive Strength in Chinese Chemical Pharmaceutical Industry for Year 2016" and the "Excellent Enterprise Brand of API Export in Chinese Chemical Pharmaceutical Industry for Year 2016".
On November 14-16, 2016, The United Laboratories (Inner Mongolia) Co., Ltd. passed the surveillance audit of the quality and environmental management system.
On September 28, 2016, the meropenem preparation and sterile API of Zhuhai United Laboratories Co., Ltd. obtained the reports issued by FDA and EIR and were permitted to enter the American market.
In September 2016, the "Technical Development Program of Tenofovir Disoproxil Fumarate" was subsidized by the special fund of Zhongshan City for major technical projects.
On September 22, 2016, Amoxy (Amoxicillin Capsules) was honored as the "Drug Brand with the Greatest Internet Influence" among alll anti-infectives.
On September 22, 2016, The United Laboratories International Holdings Limited won the "Award of Outstanding Growth in Polypeptide Compound Market of China Region in 2016".
On September 10, 2016, The United Animal Healthcare (Inner Mongolia) Co., Ltd. passed the GMP certification by Inner Mongolia Autonomous Region.
On September 6-8, 2016, the Zhuhai United Laboratories Co., Ltd. passed the BGV site inspection for the fifth time.
On August 26 to September 5, 2016, the representative of United Lab accompanied Zhu Xiaodan, the Governor of Guangdong Province during his visit to Ethiopia, Kenya and other African countries, enhancing United Lab's exploration in African market relying on the "One Belt One Road" platform.
On July 30, 2016, Zhuhai United Laboratories Co., Ltd. was honored the title of "Environmentally and Socially Responsible Enterprise of Guangdong Province".
On July 20-25, 2016, the D-p-hydroxyphenylglycine project, p-Hydroxyl phenyl glycine potassium saltne, recycled water reuse project and the new construction of two desulfurizing towers of The United Laboratories (Inner Mongolia) Co., Ltd. obtained the approval reply for environmental impact assessment report.
On July 5, 2016, the insulin detemir and injection of United Lab obtained the approval document from the State Food and Drug Administration.
In July 2016, Zhuhai United Laboratories Co., Ltd. ranked the 30th of the "Top 100 Enterprise of Chinese Pharmaceutical Industry of Year 2015".
In June 2016, two programs, i.e. the R&D and Industrialization of Genetically-engineered Drug for Diabetes Treatment - Recombinant Human Insulin Series Products, and the Technical Development and Industrialization of Drug for Neurodegenerative Diseases - Memantine Hydrochloride passed the technological achievement identification and registration.
In June 2016, the United Laboratories (China) Co., Ltd. was incorporated into and ranked the 26th of the "Top 100 Enterprise of Chinese Pharmaceutical Industry of Year 2015".
On May 30 to June 1, 2016, The United Laboratories (Inner Mongolia) Co., Ltd. passed the second EU-GMP site inspection.
On May 30, 2016, the award ceremony of "2016 United Lab Medical Educational Scholarship" was held at Fujian Medical University.
In May 2016, the Jingui Pharmaceutical Co., Ltd. of United Lab was renamed the United Animal Healthcare (Inner Mongolia) Co., Ltd.
On May 16, 2016, the United Lab won the third place and seventh place in the ranking of "High-quality Supplier and Cooperation Partner in International Market" and the "Pioneering Enterprise in Preparation Internationalization" respectively.
On May 12-16, 2016, the United Lab participated in the economic and trade cooperation exchange convention of Guangdong Province with the United States and Mexico. The United Lab was among those Chinese enterprises that entered agreements with the Mexican side on 18 cooperation projects worth USD 480 million.
On May 10, 2016, the award ceremony of "United Lab Medical Educational Scholarship" was held at Chongqing Medical University.
On April 29, 2016, the 17# Workshop of Zhuhai United Laboratories Co., Ltd. was honored the "Worker Pioneer of Guangdong Province".
On March 29, 2016, United Lab was honored as one of the "2015 Top 10 Member Enterprises of Chinese Western API and Preparation Industry for Export".
On March 23-25, 2016, The United Laboratories (Inner Mongolia) Co., Ltd. passed the SGS audit.
On March 18, 2016, Zhuhai United Laboratories Co., Ltd. and Biomerieux Company held a signing ceremony for the Microorganism Demonstration Laboratory.
On January 26-28, 2016, the United Animal Healthcare (Inner Mongolia) Co., Ltd passed the GMP certification on powder injection and sanitizer (liquid).
On December 30, 2015, Gao Gerong, the fleet foreman of Zhuhai United Laboratories Co., Ltd. was honored the "Most Beautiful Worker" of year 2015 of Zhuhai City on the "4th Enterprise Spirit Civilization Construction Exchange Convention and the Summing-up and Commendation Conference at the 20th Anniversary of Zhuhai Corporate Culture Association".
On December 9, 2015, an European client conducted CSR (corporate social responsibility) audit on amoxicillin products of The United Laboratories (Inner Mongolia) Co., Ltd.
In December 2015, insulin drugs development programs, the R&D and Industrialization of Genetically-engineered Drug for Diabetes Treatment - Recombinant Human Insulin Series Products, and the Technical Development and Industrialization of Drug for Neurodegenerative Diseases - Memantine Hydrochloride won the first prize of scientific and technological progress of Zhongshan City in year 2014 and RMB 8 million special fund for practical technology R&D projects of year 2015.
On November 16-19, 2015, The United Laboratories (Inner Mongolia) Co., Ltd. passed the certification audit of "three-standard integration" management system.
On November 9, 2015, the United Lab was listed as one of the "Top 100 Industrial Enterprises with the Strongest Comprehensive Strength in Chinese Chemical Pharmaceutical Industry for Year 2015" and honored as the "Excellent Enterprise Brand of API Export in Chinese Chemical Pharmaceutical Industry for Year 2015".
On November 6, 2015, Mr. Cai Haishan, Chairman of United Lab was awarded the "Honorary Citizen of Zhuhai City". The award ceremony was held at Zhuhai Coastal Park and the certificated granted by Jiang Ling, the Mayor of Zhuhai City.
In October 2015, the technical development program of United Lab's new antitussive drug dimemorfan phosphate capsules won RMB 1 million of subsidy by the 2015 special fund of Zhongshan City for major scientific and technological project, and is the only pharmaceutical enterprise that received the subsidy.
On September 22-25, 2015, the amoxicillin workshop of The United Laboratories (Inner Mongolia) Co., Ltd. passed the new-version GMP site inspection.
On August 21, 2015, United Lab was honored one of the "Most Popular 10 Listed Pharmaceutical Companies of Year 2015" on the award-giving meeting of Chinese pharmaceutical entrepreneur annual meeting held at Luzhou, Sichuan Province.
On August 11, 2015, the Jingui Pharmaceutical Co., Ltd. of United Lab passed the GMP certification and site acceptance inspection on the tablet and powder workshops of veterinary drug organized by the Veterinary Services of the Agriculture and Husbandry Department of Inner Mongolia.
On August 17, 2015, the United Lab donated urgently-needed drugs worth RMB 506,000 to the injured of the disastrous explosion in Tianjin for the treatment of respiratory tract infection and skin infection.
On August 10, 2015, the cornerstone laying ceremony of United Lab Massive Health Industrial Base was held at Sanzao Science and Technology Industrial Park in Zhuhai.
In August 2015, the new drug of Category 3.1 developed by the United Lab, Doripenem (0.25 g) for injection obtained the approval for clinical test by China Food and Drug Administration.
In July 2015, Zhuhai United Laboratories Co., Ltd. was honored the "Cleaner Production Enterprise" by Guangdong Provincial Cleaner Production Association.
On July 9, 2015, Chang Junzheng, the vice chairman of the People's Government of Inner Mongolia Autonomous Region, carried out site investigation at the The United Laboratories (Inner Mongolia) Co., Ltd. in the company of relevant personnel from the Environmental Protection Department of Inner Mongolia Autonomous Region and the Regional Supervision Center of West China.
In June 2015, Zhuhai United Laboratories Co., Ltd. was honored the "Research Center of Diabetes Biological Drug Engineering Technology of Guangdong Province" by the Science and Technology Department of Guangdong Province.
On June 29, 2015, United Lab was ranked the 23rdof the "Top 100 Enterprises of Chinese Pharmaceutical Industry of Year 2014" by the CFDA Southern Medicine Economic Research Institute.
On June 23, 2015, United Lab was honored the "Leading Enterprise of API Export of 2014" and the "Golden Exhibitor of CPHI API Production and Trading".
In June 2015, the Zhuhai United Laboratories Co., Ltd. received RMB 2 million of interest subsidies of Zhuhai City for supporting excellent and strong enterprises of year 2014.
In May 2015, the new antiepileptic drug developed by the United Lab, levetiracetam and levetiracetam tablets (0.25 g) obtained the production approval and new drug certificate granted by China Food and Drug Administration. The approval numbers are GYZZ H20150041 AND GYZZ H20153119; the certificate number of API is GYZZ H20150027.
In April 2015, Zhuhai Municipal Technology and Industry Informatization Bureau and Zhuhai Municipal Bureau of Finance issued jointly the Notice on Allocating R&D Subsidy Fund of Year 2013 to Enterprises of Zhuhai City, and the United Lab received a special subsidy fund of RMB 1.07 million for year 2013.
On April 6, 2015, The United Laboratories (Inner Mongolia) Co., Ltd. passed the site inspection by FDA.
On March 17, 2015, the science and technology department, the finance department, the national and local taxation bureaus of Guangdong Province issued jointly the Notice on Announcing the List of First- and Second-batch High and New Technology Enterprises of Guangdong Province in 2014; the United Lab was recognized again as a "High and New Technology Enterprise of Guangdong Province".
In 2015, Zhuhai United Lab was granted the title of "Class III Enterprise of Safety Production Standardization" by Zhuhai Work Safety and Occupational Health Association.
On March 4, 2015, Zhuhai United Laboratories Co., Ltd. was honored the "Worker Pioneer of Guangdong Province" by Guangdong Provincial Federation of Trade Unions, and won the "May First Heroine Award of Guangdong Province" by Guangdong Provincial Federation of Trade Unions and the Women's Federation of Guangdong Province.
On February 5, 2015, the 17# Workshop of Zhuhai United Laboratories Co., Ltd. was honored the "Worker Pioneer of Guangdong Province" of year 2014 by Zhuhai Municipal Federation of Trade Unions.
On January 27-31, 2015, the new drugs of Category 3.1 declared for registration by the United Lab, levetiracetam and levetiracetam tablets passed the production site inspection by the expert inspection team from China Food and Drug Administration.
In 2014, United Lab granted a total of RMB 1.03 million of United Lab scholarship at 8 medical colleges.
On November 26, 2014, United Lab was honored as one of the "Top 100 Industrial Enterprises with the Strongest Comprehensive Strength in Chinese Chemical Pharmaceutical Industry for Year 2014" and the "Excellent Enterprise Brand of API Export in Chinese Chemical Pharmaceutical Industry for Year 2014".
On November 14, 2014, seven workshops of Zhuhai United States Co., Ltd. passed the GMP certification inspection by Guangdong Province. The certification scope covers sterile APIs: biapenem, ceftriaxone sodium, sulbactam sodium, cefpirome sulfate; APIs: cefdinir, cefuroxime axetil, bendazac lysine, tazobactam, sulbactam pivoxy. Most of these 10 drugs belong to small varieties, of which biapenem and cefdinir are certificated for the first time after obtaining the approval document.
On October 7-10, 2014, the 10# and 4# workshops of Zhuhai United Lab passed the official certification inspection by Romanian GMP.
On October 23, 2014, the 2nd Council Meeting of the 3rd China National Narcotic Drugs Association organized by the United Lab was held in Zhuhai.
On September 3-4, 2014, a total of 154 employees of United Lab participated in voluntary blood donation at Zhuhai Blood Station, offering 53,400 ml of blood in total.
On the morning of August 20, 2014, leaders of Inner Mongolia Autonomous Region headed by Wang Jun, the Party Secretary and Bartel, the Chairman of the Autonomous Region, visited The United Laboratories (Inner Mongolia) Co., Ltd. for site investigation and inspection.
In June 2014, the United Lab established the sixth wholly-owned subsidiary, Jingui Pharmaceutical Co., Ltd. amid its efforts to explore the field of veterinary medicinal products.
On June 4, 2014, the product developed by the United Lab for children drug market, Piperacillin Sodium and Tazobactam Sodium for Injection (4:1) (specifications: 0.625 g) obtained production approval numbered GYZZ H20143181. According to data from CFDA, only three enterprises in China were granted the marketing license of the product in such specifications.
On June 17, 2014, the new drug of Category 3.1 developed by the United Lab, biapenem API and preparation obtained the registration approval and new drug certificate by CFDA, making the United Lab the fifth manufacturer of such variety in China.
In 2014, the Tenofovir Disoproxil Fumarate (TDF) Tablets developed by the United Lab for the treatment of hepatitis B virus (HBV) obtained the clinical test approval document for new drug granted by China Food and Drug Administration.
On June 25, 2014, Zhuhai United Laboratories Co., Ltd. was honored the "Top 10 Export Enterprises of Western APIs in China" and the "Pioneering Chinese Pharmaceutical Enterprise in Preparation Internationalization".
On June 12, 2014, the investigation group headed by Wang Pujun, director of Environmental Protection Bureau of Inner Mongolia Autonomous Region, conducted investigation on the supporting construction of environmental facilities of environmental projects of The United Laboratories (Inner Mongolia) Co., Ltd. The investigation group was received by Cai Haishan, chairman of United Lab.
On May 23-24, 2014, Bie Tao, deputy director of MEP Department of Policies and Laws, engineers represented by Zhang Fan, researcher and director of CRAES Air Pollution Control Research Center, and experts from the Ecology and Environment College of Xiameng University visited and investigated The United Laboratories (Inner Mongolia) Co., Ltd.
Biapenem API and preparation, new drugs of Category 3.1 declared by the United Lab, passed the production site inspection by CFDA for drug registration. The project entered the "three-in-one" review stage and is predicted to obtain the production approval by August this year. Meanwhile, the piperacillin sodium and tazobactam sodium for injection (4:1) of United Lab in specifications of 1.25 g and 2.5 g passed the reexamination and would also be approved for production.
On May 1, 2014, the FOB section in the recovery workshop of The United Laboratories (Inner Mongolia) Co., Ltd. was honored as the "Worker Pioneer of Inner Mongolia Autonomous Region".
On April 23, 2014, Mr. Cai Haishan, Chairman of United Lab was nominated as the "Senior Vice-chairman" of China Pharmaceutical Enterprise Management Association on its 7th general assembly.
On April 22, 2014, the API mixed powder of Zhuhai United Laboratories Co., Ltd. passed the GMP certification inspection by Guangdong Provincial Food and Drug Administration.
On March 29, 2014, the inaugurating meeting of Specialized Committee of anti-aging and cerebral degenerative disease control under Guangdong Provincial Healthcare Association, and the release conference of "Yi Bei Qing" was held in Zhuhai.
On March 19, 2014, Zhuhai United Laboratories Co., Ltd. was honored as one of the “Top 5 Export Enterprises of Chinese Western API Industry" on the 3rd session of the 6th China Chamber of Commerce for Import & Export of Medicines and Health Products.
In 2013, the recombinant human insulin of United Lab was allocated with RMB 10 million of special development fund by the central finance.
On December 27, 2013, the trademark "United Lab" held by Zhuhai United Laboratories Co., Ltd. was recognized by the State Administration of Industry and Commerce as the "Famous Brand" of China.
In 2013, The United Laboratories (Inner Mongolia) Co., Ltd was granted the CEP Certificate (Certificate No.: R0-CEP 2012-078-Rev 00) for enzymatic amoxicillin by European Directorate for the Quality of Medicines (EDQM), making it United Lab's first subsidiary that obtains such certificate.
In 2013, Memantine Hydrochloride, a new drug developed by United Lab for treating Alzheimer's disease received RMB 5 million of special finance subsidy by Zhongshan City.
In 2013, United Lab implemented proactively the API brand strategy and formulates the "Golden Swallow" and "Silver Swallow" programs in order to meet the needs of market development. The "Golden Swallow" program comprises potassium clavulanate sterile products, while the "Silver Swallow" program involves potassium clavulanate non-sterile products. The "Golden Swallow" and "Silver Swallow" series products have passed the Chinese-version GMP certification and the GMP certification by foreign countries including the United Sates (FDA), Germany, Romania (NDA) and Mexico.
On November 24, 2013, the sterile production workshop of Zhuhai United States Co., Ltd. passed the new-version GMP certification.
On November 13, 2013, Chairman Cai Haishan was granted the title of "Honorary Citizen of Zhongshan City".
In November 2013, all the 11 workshops of United Lab Zhongshan passed the new-version GMP certification.
On September 4, 2013, The United Laboratories (Inner Mongolia) Co., Ltd passed the site inspection EU-GMP certification, laying a foundation for the entry of Amoxy APIs into the EU market.
In 2013, 2# group from the operation section of Environmental Protection Center of The United Laboratories (Inner Mongolia) Co., Ltd. was honored the "National Worker Pioneer" by the All-China Federation of Trade Unions.
On July 17, 2013, United Lab won the title of the "Best Industrial Enterprise of Year 2013 in China for Medical R&D Line".
On July 16, 2013, the API, oral solution and tablets of memantine hydrochloride, a new drug developed by United Lab for treating Alzheimer's disease obtained the registration approval document and related document No. by China Food and Drug Administration, making it the first enterprise that is granted with the permit to produce memantine hydrochloride series products.
On June 17, 2013, United Lab was ranked the 21st on the "Top 100 of Chinese Pharmaceutical Industry of Year 2012" on the 8th annual meeting of the ranking list held by SFDA Southern Medicine Economic Research.
On June 5, 2013, Zhuhai Branch of Bank of China signed a strategic cooperation agreement with United Lab to grant a credit of RMB 2 billion to United Lab explore markets.
In 2013, United Lab was recognized as one of the 100 key "three high and one special" enterprises to be cultivated of Zhuhai City, allowing it to enjoy related preferential policies of the government.
On May 20-31, 2013, Zhuhai United Laboratories Co., Ltd. and The United Laboratories (Inner Mongolia) Co., Ltd passed the official site inspection by Mexico. The production of amoxicillin (chemical method), potassium clavulanate microcrystalline cellulose (1:1), potassium clavulanate silicon dioxide (1:1) and amoxicillin (enzymatic method) were recognized officially by Mexico and passed the production site inspection without any defect.
On April 20, 2013, Ya'an City of Sichuan Province was hit by a magnitude 7.0 earthquake; a million of people were affected. United Lab donated antibiotic antiphlogistics worth RMB 1 million to the hit area immediately.
At 16:08, April 15, 2013, Mr. Cai Jinle, a famous industrialist, founder of United Lab and Board Chairman of The United Laboratories International Holdings Limited died from disease at Hong Kong Union Hospital at the age of 72.
On March 3, 2013, the clinical test summary meeting of "Tong Feng Xian" brand Febuxostat Tablets, a new drug developed by United Lab was held at Shanghai, marking the entry of United Lab into the field of treatment of rheumatism and immunity diseases.
Zhuhai United Laboratories Co., Ltd. brought good news: the API sales in the first half of 2012 reached RMB 2.54 billion, including RMB 1.72 billion contributed by Zhuhai API Factory, RMB 640 million by Inner Mongolia Plant and RMB 180 million by Chengdu Plant, an increase of 22.5% on a year-on-year basis.
The annual sales of 2012 attained RMB 4.8 billion.
The fourth and fifth phases of the expansion project of The United Laboratories (Inner Mongolia) Co., Ltd with a total investment of RMB 4.09 billion proceeded smoothly and were predicted to be completed and put into trial operation in November 2012 and October 2013 respectively.
In 2012, Zhuhai United Laboratories Co., Ltd. was recognized as a "High and New Technology Enterprise" of Guangzhou Province and entitled to enjoy the preferential taxation policy for a period of three years.
In 2012, the recombinant human insulin of United Lab was allocated with RMB 10 million of special development fund by the central finance.
In 2012, United Lab became the first FDA-certificated producer of sterile powder injection in China.
In 2012, summary-up meeting for the clinical test of "USLEN" (Recombinant Insulin Glargine Injection) was held successfully.
United Lab was ranked the first among antibiotic API export enterprises in China for year 2011.
In 2012, imipenem sterile API and cilastatin sodium API were granted with the EU COS certificate; the United Lab Ampicillin Trihydrate obtained the EU COS certificate; the penem sterile preparation and sterile API workshops passed the site inspection by FDA.
On September 17-18, 2012, the management committee of United Lab Zhongshan and Zhuhai United Lab was established.
On July 13, 2012, the "Top 100 Enterprises in Chinese Pharmaceutical Industry for Year 2011" was published, and the United Laboratories International Holdings Limited was ranked the 14th on the list, five places ahead compared to 2010.
On July 5, 2012, The United Laboratories International Holdings Limited donated RMB 1.8 million to Bayannur City of Inner Mongolia Autonomous Region for flood relief and homeland rebuilding, of which RMB 1 million was contributed by the company and the other RMB 800,000 by employees.
In June 2012, supported by the Policy Research Office of Guangdong Provincial Party Committee and financed by United Lab, the construction of ZhongXinDong Yao Nationality ZhengYan New Village, Youxi Town, Ruyuan Yao Autonomous County, Guangdong Province was completed.
On April 29, 2012, United Lab signed the 3rd "United Lab Medical Education Scholarship" Donation Agreement with Central South University, offering another RMB 1 million as scholarship. The "United Lab Medical Education Scholarship" had so far granted RMB 3 million in total since 1998.
On February 28, 2012, the sterile imipenem of Zhuhai United Laboratories Co., Ltd. was granted the CEP certificate by EDQM, making United Lab the first in China and the second enterprise in the world that owns a CEP certificate for sterile imipenem. This is also the first sterile product CEP certificate obtained by United Lab.
On January 30, 2012, United Lab's ampicillin API obtained the CEP certificate (certificate No.: R0-CEP 2010-09) granted by European Directorate for the Quality of Medicines (EDQM).
In 2011, the amoxicillin API workshop of The United Laboratories (Inner Mongolia) Co., Ltd passed the GMP certification.
In 2011, United Lab won the Award of Outstanding Technological Contribution of Zhuhai City and was rewarded with RMB 1 million by Zhuhai Municipal Government.
In 2011, United Lab invested another RMB 10 million to improve the environmental facilities of Zhuhai United Laboratories Co., Ltd.
United Lab published at Hong Kong its interim results of 2011, announcing a sales of HKD 3.37 billion, a year on year increase of 9.6%.
In 2011, United Lab ranked among the list of "Top 100 Enterprises in China Pharmaceutical Industry".
In 2011, United Lab was ranked among the "Top 20 Listed Companies in China Pharmaceutical Industry" of its third event.
In 2011, Orlistat Capsules of 2# oral solid workshop and the Clindamycin Phosphate Gel of 6# ointment workshop, United Lab Zhongshan, passed the production site inspection by the expert group from China Food and Drug Administration.
In July 2011, United Lab "Amoxy" was recognized as the national famous brand.
In June 2011, United Lab passed the new-version GMP sterile API certification.
In April 2011, United Lab was honored one of the "Top 100 Enterprises at Chemical Pharmaceutical Industry Brand Summit 2011", the "Top 10 Export-orientated Enterprises of Chemical Pharmaceutical Industry 2011" and "Top 10 Anti-infective Product Brands of Chemical Pharmaceutical Industry 2011".
In 2010, United Lab's API sales reached RMB 4.52 billion.
In 2010, the newly-built 16# oral solid workshop and #18 lyophilized powder workshop also passed the GMP certification.
In 2010, 1# oral penicillin workshop, 2# oral solid workshop, 3# oral solution workshop of United Lab Zhongshan passed the GMP re-certification smoothly; the United Laboratories International Holdings Limited won the "2011 Outstanding Enterprises of Hong Kong (Main Board)" granted by Economic Digest, a famous financial magazine in Hong Kong.
In 2010, the capsules (penicillin) of The United Laboratories (Inner Mongolia) Co., Ltd. passed the GMP certification.
In 2010, the Quality Inspection Center of Zhuhai API Factory passed the laboratory accreditation review.
In 2010, phase II of environmental project of The United Laboratories (Inner Mongolia) Co., Ltd. passed the acceptance inspection by the Academy of Environmental Sciences of Inner Mongolia Autonomous Region.
In 2010, the energy conservation technology reconstruction project of Zhuhai United Laboratories Co., Ltd. was put into trial operation.
In 2010, the "Education and Innovation Base of Postgraduates in Immunology of Guizhou Province" established jointly by United Lab and Zhuhai Campus of Zhunyi Medical College held the opening ceremony at Zhuhai API Factory.
In April 2010 right after Yushu, Qinghai was hit by an earthquake, United Lab donated through Zhuhai Charity Federation drugs worth RMB 500,000 to the victims; besides, United Lab's employees donated voluntarily RMB 100,000 to the disaster-stricken people.
In 2010, the recombinant human insulin developed by United Lab obtained the production approval of China Food and Drug Administration and was marketed successfully in the trade name of USLIN.
In 2010, the United Laboratories International Holdings Limited held a performance press conference at Hong Kong, announcing a sales of United Lab in 2010 of HKD 6.503 billion, an increase of 40.1% from the previous year, and the profit attributable to equity shareholders was around RMB 974 million, an increase of 79.9% on a year-on-year basis. The Board of Directors decided to distribute HKD 0.018 of final dividend, bringing the total annual dividend payout to HKD 0.03.
In 2010, United Lab invested and built up an insulin API and preparation production site in Zhuhai in order to explore the market of recombinant insulin products comprehensively.
In 2010, United Lab was honored the "Backbone Enterprise of Strategic Emerging Industry in Guangdong Province".
In 2010, United Lab won the science and technology award of Zhuhai City 2009 and received RMB 1 million reward from Zhuhai Municipal Government.
In 2010, the "United Lab Charity Hospital" built with RMB 12 million of donation by Mr. Cai Jinle held an inauguration ceremony.
In 2009, United Lab was listed as one of the "Top 20 Chemical Drug API and Preparation Enterprises of Guangdong Pharmaceutical Industry" and "Top 20 Enterprises with the Highest Site Sales of Pharmaceutical Industry" by Guangdong Pharmaceutical Profession Association based on the evaluation on enterprises' comprehensive indicators.
In 2009, Zhuhai United Laboratories Co., Ltd. and United Lab Zhongshan were recognized jointly by the department of science and technology, finance department, national tax bureau and local tax bureau of Guangdong Province as a "High and New Technology Enterprise of Guangdong Province", and were entitled to enjoy the income tax preferences for a period of three years.
In 2009, United Lab was recognized jointly by six departments including department of science and technology, intellectual property office and development and reform commission of Guangdong Province as the "Innovation Enterprise of Guangdong Province ".
In 2009, United Lab obtained the mark of "Cleaner Production Partner of Guangdong and Hong Kong" of Guangdong Province.
In September 2009, Mr. Cai Lejin donated RMB 5 million to the Medical Development and Aid Fund of Nanjing Drum Tower Hospital.
In 2009, United Lab's new products, Bendazac Lysine Eye Drops and Compound Chondroitin Sulfate Eye Drops (both of which are OTC drugs) obtained the official approval from China Food and Drug Administration and started formal production.
In 2009, a delegation headed by Hu Chunhua, Party Secretary of Inner Mongolia Autonomous Region paid a visit to The United Laboratories (Inner Mongolia) Co., Ltd.
In 2009, Chairman Cai Jinle was honored the title of "60 Persons of Chinese Pharmaceutical in 60 Years".
In 2009, United Lab was ranked among the top 20 listed pharmaceutical companies in China with the greatest competitiveness.
In 2009, the United Laboratories International Holdings Limited became the first in pharmaceutical industry to attain the honorable title of "Excellent Brand and Enterprise of Environmental Protection of 2009"..
In 2009, United Lab's Amoxicillin Compacted Powder was granted with the COS (Certificate of Suitability) by European Directorate for the Quality of Medicines (EDQM), making it the first Chinese pharmaceutical enterprise that passes the FDA site inspection on ampicillin.
In 2009, Wang Yang, member of the Political Bureau of the CPC Central Committee and Party Secretary of Guangdong Province paid an inspection visit to United Lab and provided inscription.
In 2009, United Lab donated RMB 12 million to build "United Lab Charity Hospital" at Pengzhou City, Sichuan.
In 2009, the D-acid project of The United Laboratories (Inner Mongolia) Co., Ltd. was put into production.
In 2009, phase III expansion of United Lab Zhongshan was completed.
In 2009, phase V expansion of Zhuhai United Laboratories Co., Ltd. was completed and put into production.
In 2008, the second "United Lab Medical Education Scholarship" kicked off and a donation and assistantship agreement was concluded with West China College of Sichuan University, Chongqing Medical University, Hsiang-Ya Medical College of Central South University and Shenyang Pharmaceutical University, upon which RMB 10 million was donated.
In 2008, United Lab's ampicillin API passed the compliance survey by Japanese pharmaceuticals GMP.
In 2008, United Lab won the Outstanding Enterprise Achievement Award of Capital China, which is the "Outstanding Pharmaceutical Group of Capital China".
In 2008, United Lab won the "Outstanding Contribution Award of Guangdong Pharmaceutical Industry for 30 Years since the Opening-up".
In 2008, United Lab was appraised as the "Model Group of Earthquake Relief".
On May 12, 2008, a great earthquake hit Wenchuan and United Lab stretched its helping hand by donating drugs worth over RMB 5 million. Besides, United Lab's employees donated RMB 800,000 to the disaster-stricken area under the leadership of party members and league member of the company.
In 2008, United Lab was honored the "Social Citizen Award" on the award ceremony of "30 Years of Chinese Pharmaceutical Industry" held by China Pharmaceutical Enterprise Management Association and health.sohu.com.
In 2008, United Lab won the "Enterprise Social Responsibility Contribution Award" for Chinese pharmaceutical enterprises.
In 2008, United Lab's Amoxy Capsules was included in the "Healthy China - 2008 Chinese Pharmaceutical Brand List".
In 2008, Imipenem and Cilastatin Sodium for Injection, drug developed by United Lab independently obtained the production approval by China Food and Drug Administration.
In 2008, ampicillin and cefoperazone sodium APIs and their preparations are listed as a high and new technology product of Guangdong Province.
In 2008, adefovir dipivoxi was included in the national level torch program and recognized as a national-level key new product and high and new technology product of Guangdong Province.
In 2007, United Lab was recognized as a provincial-level enterprise and technology center of Guangdong Province.
In 2007, A Di Xian (Adefovir Dipivoxil Capsules), United Lab's first new drug for treating Chronic Hepatitis.
In 2007, the Amoxy product of Zhuhai United Laboratories Co., Ltd. obtained COS (Certificate of Suitability) granted by European Directorate for the Quality of Medicines (EDQM) and the DMF acceptance Number of FDA and passed the German GMP certification.
In 2007, Zhuhai United Laboratories Co., Ltd. was recognized as one of the headquarter enterprises in Zhuhai City.
On June 15, 2007, the United Laboratories International Holdings Limited was listed on Hong Kong Stock Exchange.
In 2007, the plant of The United Laboratories (Inner Mongolia) Co., Ltd. was built up and put into production.
In 2007, the plant of The United Laboratories (Chengdu) Co., Ltd. built up and put into production.
In 2006, trade mark "United Lab" was recognized by Guangdong Provincial Famous Trademark Recognition Board as the famous trademark of Guangdong Province.
In 2006, United Lab was regarded by Medical Economy as one of the top 100 enterprises of Chinese pharmaceutical industry.
In July 2016, United Lab donated drugs worth RMB 20,000 to Shaoguan and Lechang which were hit by flood.
In 2006, the amoxicillin workshop became the first workshop in China that passes German GMP certification.
In 2005, United Lab was honored as one of the top 50 pharmaceutical enterprises by the Pharmaceutical Industry Association of Guangdong Province.
In 2005, United Lab donated drugs and cash equivalent to RMB 30,000 to the People's Liberation Army garrison in Macau.
In 2005, United Lab donated RMB 100,000 to the education facility and information construction of Jinwan District, Zhuhai City, in the hope of helping more students to receive high-quality education.
In 2005, United Lab encouraged its employees and affiliates to donate RMB 50,000 to the areas hit by Indian Ocean Tsunami.
In 2005, trade mark "Tazocin" was recognized by Guangdong Provincial Famous Trademark Recognition Board as the famous trademark of Guangdong Province.
In 2005, Levofloxacin Hydrochloride Eye Drops was recognized as the key new product of Guagdong Province.
In 2005, Guangdong Provincial Department of Science and Technology approved the establishment of the "Engineering R&D Center of Anti-infective Drug of Guangdong Province".
In December 2005, United Lab was recognized as the "Key Enterprise Technology Center of Zhuhai City".
In August 2005, United Lab donated RMB 50,000 to a charity organization of Guangdong Province.
In August 2005, United Lab donated RMB 1 million and established the "United Lab New Oriental English Workshop" in support of the education development of poverty-stricken areas in Bijie City, Guizhou Province.
On June 1, 2005, United Lab obtained the "Qualification Certificate of High and New Technology Enterprise".
In 2004, shift C of synthesis section in 4# workshop of Zhuhai United Laboratories Co., Ltd. was honored as the "National Advanced Shift of China Pharmaceutical Industry".
From 2004 to 2007, United Lab renewed the scholarship agreement with Shenyang Pharmaceutical University and Tongji Medical University, and donated RMB 300,000 medical education scholarship.
In 2004 and 2007, Amoxicillin Granules was recognized as the "Famous-brand Product of Guangdong Province" by Administration of Quality and Technology Supervision of Guangdong Province.
In 2004, Ceftriaxone Sodium was included in the national-level torch program.
In 2003, United Lab was appraised as a model enterprise in pharmaceutical industry of Guangdong Province in fighting against SARS.
In 2003, United Lab was listed as one of the top 500 enterprises of Chinese chemical industry.
In 2003, United Lab was honored the title of "Advanced Group of Guangdong Province" by the party committee and government of Guangdong Province.
In 2003, Zhuhai United Laboratories Co., Ltd. was listed as a key high and new technology enterprise of national torch program.
In 2003, United Lab donated drugs worth RMB 35,000 to Beijing Xiaotangshan Hospital through Guangdong Medical Industry Association in the crisis of SARS.
In 2003, Amoxicillin Capsules, Amoxicillin Granules, Ampicillin Capsules, Compound Codeine Phosphate Oral Solution and Potassium Guaiacolsulfonate and Codeine Phosphate Oral were recognized by Guangdong Medical Industry Association as the "Famous-brand Product of Guangdong Province".
In 2003, United Lab was approved by the Ministry of Science and Technology to establish a Post-Doctoral Research Center.
In 2003, Sulbactam Pivoxyl and Amoxicillin sulbactam Pivoxil Tablets were included in the national torch program.
In 2003, Chengdu United Labratories Co., Ltd. was established and the "medical intermediate" production site was set up.
In 2002, Amoxy was listed as one of the top 10 brands of "2002 (First) Quality Reputation Competitiveness Survey on Consumables in Chinese Market".
In 2002, United Lab donated drugs worth around RMB 100,000 to overty-stricken women in Zhuhai City on the opening ceremony of the "Caring for Poverty Alleviation Campaign" hosted by Zhuhai Municipal Women's Federation.
In 2001, United Lab donated RMB 600,000 to disabled children schools through the Happy Dictionary, a program of CCTV.
In 2001, Tazobactam and Tazobactam Sodium and Piperacillin Sodium for Injection were recognized as national key new products.
In 2001, Amoxicillin Capsules were marketed with the approval from the State.
In 2001, Zhuhai United Laboratories Co., Ltd. finished its shareholding reform.
In 2000, Compound Codeine Phosphate Oral Solution was recognized as a key new product in Guangdong Province.
In 2000, United Lab was awarded the title of "Model Group of Zhuhai City from 1997 to 1999" by the party committee and government of Zhuhai City.
In August 1999, registered trademark "United Lab" was approved as an official legal trademark by the trademark registration certificate numbered 1199808 issued by the Trademark Office of State Administration for Industry and Commerce of the People's Republic of China.
In 1999, United Lab was recognized as a high and new technology enterprise of Guangdong Province.
In 1998, United Lab donated touch-type computer medical guide system to nearly 100 affiliated hospitals of medical colleges in support of the scientific and standardized management of hospitals.
In 1998, United Lab donated RMB 2 million and set up the "Young Scientist Fund of Guangdong Province and the "Grant for Impoverished College Students of Guangdong Province" to support and encourage scientists with outstanding contribution and college students with special hardship and high academic and moral performance.
In 1998, a heavy flood disaster hit the Yangtze River basin, and United Lab donated drugs worth RMB 1 million to stricken areas in Hubei Province to support the normal functioning of medical services.
In 1998, Zhuhai API Factory was completed. Occupying an area of 250,000 m2 with a greening rate of about 40%, it is a large-scale modernized and high-technology synthetic pharmaceutical enterprise mainly engaged in the production of semi-synthetic antibiotic APIs and passed the national GMP certification in July of the same year.
From 1998 to 2003, United Lab donated RMB 38 million and established "United Lab Medical Education Scholarship" in 36 medical colleges nationwide to award the postgraduates and undergraduates on campus with good performance in both character and learning.
In 1997, Cai Jinle, president of United Lab was granted with the title of "Honorary Citizen of Zhuhai City" by the People's Government of Zhuhai City.
On December 10, 1997, five production workshops of United Lab Zhongshan passed the national GMP certification all at the first try, making it one of the first comprehensive pharmaceutical enterprises having all their dosage forms certified by GMP.
In October 1997, United Lab Zhongshan was completed and put into production officially.
On May 28, 1997, United Lab Fedix obtained the new drug certificate and production approval by the Ministry of Health.
In 1997, United Lab donated over RMB 700,000 and set up the "United Lab Scholarship" at China Medicine University.
In 1997, United Lab donated RMB 1.8 million, established the Drug Research Institute of Wuhan Tongji Medical University and set up the "United Lab Scholarship".
In 1996, United Lab donated RMB 1.5 million, established the College of Business Administration in cooperation with Shenyang Pharmaceutical University and set up the "United Lab Scholarship".
In October 1996, Ampicillin Capsules, Amoxy Capsules and Amoxy Dry Syrup obtained the price approval documents by Guangdong Price Bureau; the Sai Fu-series obtained the price approval documents from the same by the end of 1997.
In May 1996, Ampicillin Capsules, Amoxy Capsules, Amoxy Dry Syrup and Sai Fu-series obtained the production approval from Guangdong Provincial Department of Public Health and were marketed smoothly.
In 1994, United Lab donated over RMB 1 million to disaster-stricken people of Guangxi, Hunan and Hebei provinces which are hit by natural disasters.
On December 1, 1994, the construction project of United Lab Zhongshan was commenced officially. The plant occupies an area of 35,000 m2 with a floorage of 20,000 m2 and green area taking up over 30%.
In 1994, Zhongshan Preparation Factory was established, which comprises a preparation factory, an API factory and Kingly Capsules Factory, wherein the preparation factory occupies an area of 60,000 m2, and API factory 250,000 m2.
In 1994, United Lab China Marketing Division was established and staffed a young and high-quality team with abundant marketing-related knowledge and expertise, and over 20 offices were opened in large and medium-size cities nationwide, stretching the sales network to every corner in China.
In 1991, United Lab's products entered the mainland market by the first introduction of Amoxy Capsules and Compound codeine Phosphate Oral Solution, popularizing the use of oral semi-synthetic penicillin which requires no skin test, while exploring the prohibited area for the use of codeine drugs, changing the medication habit of Chinese people and pushing forward the development of pharmaceutical industry in China.
In late 1990s, Anticol was transferred to Shenzhen Pharmaceutical Factory.
In early 1990s, Anticol, Isedyl and Dioxoprothazine were sold to mainland market.
In early 1990s, Hong Kong United Laboratories Co., Ltd. entered mainland China and established Zhuhai United Laboratories Co., Ltd.